Managing Impulsivity and Substance Abuse in an Adolescent with Attention-deficit Hyperactivity Disorder: Potential for Endoxifen Therapy.
作者信息
Banerjee Debanjan
机构信息
Apollo Multispecialty Hospitals, Kolkata, West Bengal, India.
出版信息
Indian J Psychol Med. 2025 Aug 15:02537176251365813. doi: 10.1177/02537176251365813.
Abstract
摘要
相似文献
1
Managing Impulsivity and Substance Abuse in an Adolescent with Attention-deficit Hyperactivity Disorder: Potential for Endoxifen Therapy.
Indian J Psychol Med. 2025 Aug 15:02537176251365813. doi: 10.1177/02537176251365813.
3
Dietary Alignment with the Mediterranean Diet is Associated with a Lower Risk of Attention Deficit Hyperactivity Disorder in University Students: A Cross-Sectional Study.
J Am Nutr Assoc. 2025 Sep-Oct;44(7):636-643. doi: 10.1080/27697061.2025.2480140. Epub 2025 Apr 4.
4
[Substance Use Disorder as a Comorbidity in Patients with Attention Deficit Hyperactivity Disorder].
Acta Med Port. 2025 Jun 2;38(6-7):398-407. doi: 10.20344/amp.21937. Epub 2025 Apr 28.
5
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
6
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
7
Family therapy for attention-deficit disorder or attention-deficit/hyperactivity disorder in children and adolescents.
Cochrane Database Syst Rev. 2005 Apr 18(2):CD005042. doi: 10.1002/14651858.CD005042.pub2.
8
Comparative effectiveness of various physical exercise interventions on executive functions and related symptoms in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis.
Front Public Health. 2023 Mar 24;11:1133727. doi: 10.3389/fpubh.2023.1133727. eCollection 2023.
9
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
10
Methylphenidate for children and adolescents with autism spectrum disorder.
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
本文引用的文献
1
Endoxifen in Treatment of Individuals with Borderline Personality Disorder with Predominant Impulsivity: A Case Series.
Consort Psychiatr. 2023 Dec 22;4(4):66-73. doi: 10.17816/CP13622.
2
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder.
Bipolar Disord. 2021 Sep;23(6):595-603. doi: 10.1111/bdi.13041. Epub 2021 Jan 9.
3
Ethanol-Induced Changes in PKCε: From Cell to Behavior.
Front Neurosci. 2018 Apr 12;12:244. doi: 10.3389/fnins.2018.00244. eCollection 2018.
4
Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens.
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16080-5. doi: 10.1073/pnas.1106277108. Epub 2011 Sep 12.
5
Triadic model of the neurobiology of motivated behavior in adolescence.
Psychol Med. 2006 Mar;36(3):299-312. doi: 10.1017/S0033291705005891.
6
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory.
Science. 2004 Oct 29;306(5697):882-4. doi: 10.1126/science.1100021.
7
The Strengths and Difficulties Questionnaire: a research note.
J Child Psychol Psychiatry. 1997 Jul;38(5):581-6. doi: 10.1111/j.1469-7610.1997.tb01545.x.
Zotero 插件